3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
2
Lymphoid
1
Conditions
Uterine Cervical Neoplasms
1
Lymphoma, Follicular
1
Endometrial Neoplasms
1
Disease
1
Interventions
pembrolizumab
3
copanlisib
2
aflibercept
2
X-Rays
2
Specimen Handling
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
temsirolimus
1
selinexor
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
epacadostat
1
enzalutamide
1
entinostat
1
defactinib
1
dabrafenib
1
ciforadenant
1
capivasertib
1
binimetinib
1
atezolizumab
1
adavosertib
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Diffusion Magnetic Resonance Imaging
×
Lymphoid
×
Clear all
NCT01836484
2020-02-13
MAPPING
Barts & The London NHS Trust
Completed
162 enrolled